Cytotoxic Therapy for Advanced Adrenocortical Carcinoma
Author Information
Author(s): R Bonacci, A Gigliotti, E Baudin, N Wion-Barbot, P Emy, M Bonnay, AF Cailleux, I Nakib, M Schlumberger
Primary Institution: Institut Gustave Roussy
Hypothesis
The combination of etoposide and cisplatin will be effective in treating advanced adrenocortical carcinoma.
Conclusion
The combination of etoposide and cisplatin resulted in a 33% overall response rate in patients with advanced adrenocortical carcinoma.
Supporting Evidence
- A complete response was observed in three cases.
- A partial response was observed in three cases.
- Tumour response was noted in three of the six patients with progressive disease during treatment.
Takeaway
Doctors tried a new medicine to help people with a rare type of cancer, and it worked for some of them.
Methodology
18 patients with advanced adrenocortical carcinoma were treated with etoposide and cisplatin every 4 weeks, while monitoring mitotane levels.
Limitations
The study had a small sample size and the response rates were relatively low.
Participant Demographics
Median age was 46 years, with 11 females and 7 males.
Want to read the original?
Access the complete publication on the publisher's website